Non-inferiority Bioavailabilty Study of 3 Silicon-rich Supplements

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

June 30, 2017

Study Completion Date

July 30, 2017

Conditions
Absorption; Disorder
Interventions
DIETARY_SUPPLEMENT

Prod1

60 mL of product (water, silicic acid, Equisetum Arvense, Rosmarinus officinalis) (Silicic acid) equivalent to 21.6 mg of elemental silicon.

DIETARY_SUPPLEMENT

Prod2

1.4 g of product (Orthosalicic acid) equivalent to 21.6 mg of elemental silicon

DIETARY_SUPPLEMENT

Prod3

120 mL of product (Aloe barbadensis Miller, organic silicon, potassium sorbate, cítric acid) (Organic silicon) equivalent to 21.6 mg of elemental silicon

Trial Locations (1)

43204

Technological Centre of Nutrition and Health (CTNS), Reus

All Listed Sponsors
collaborator

SILICIUM ESPAÑA LABORATORIOS SLU

UNKNOWN

collaborator

Hospital Universitari Sant Joan de Reus

OTHER

collaborator

University Rovira i Virgili

OTHER

lead

Technological Centre of Nutrition and Health, Spain

OTHER

NCT03108508 - Non-inferiority Bioavailabilty Study of 3 Silicon-rich Supplements | Biotech Hunter | Biotech Hunter